N/A N=200 Randomized Treatment

Feasibility and Effectiveness of a Specialized Brief Intervention for Hazardous Drinkers in an Emergency Department.

Alcohol Drinking

Bottom Line

View on ClinicalTrials.gov: NCT03273283 ↗

Enrolled (actual)

200

Serious AEs

0.0%

Results posted

May 2020

Primary outcome: Primary: Proportion of Risky Drinkers Measured by AUDIT-C — 20; 39 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Brief Intervention (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Hospital Clinic of Barcelona
Primary completion: Feb 2018

Outcome Measures

Outcome	Result	p-value
PRIMARY Proportion of Risky Drinkers Measured by AUDIT-C	20; 39	—
PRIMARY Proportion of Patients Attending to Specialized Treatment	17; 8	—

Summary

Alcohol use and its consequences represent an important public health problem. As well as alcohol dependence, hazardous drinking also contributes to a high burden in terms of morbidity and mortality. To improve these patients' prognosis and decrease associated social and health care costs, it is necessary to increase early detection, intervention and treatment for these problems. For these reasons, SBIRT programmes (Screening Brief Intervention and Referral to Treatment) have been developed, evaluated and shown to be effective, particularly in primary care and general practice. Nevertheless, effectiveness of SBIRT in emergency departments (ED) has not been clearly established. The investigators aimed to evaluate the feasibility and efficacy of an SBIRT programme in the ED of a tertiary hospital.

Eligibility Criteria

Inclusion Criteria

All patients aged 18 or older attending to the emergency department were potentially eligible patients
Patients with an AUDIT-C score higher than 6 points for men and 5 for woman were invited to participate

Exclusion Criteria

Cognitive impairment
Medically unstable
Patients explicitly demanding alcohol treatment

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03273283). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.